Cargando…
P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431141/ http://dx.doi.org/10.1097/01.HS9.0000971324.63506.62 |
| _version_ | 1785091130477510656 |
|---|---|
| author | Flinn, Ian W. Jacobson, Caron Nastoupil, Loretta J. Morschhauser, Franck Davies, Andrew J. Buske, Christian Corradini, Paolo Lopez-Guillermo, Armando Reshef, Ran Parameswaran, Vinod Sehgal, Alison Tees, Michael Lui, Christine Xue, Wei Beygi, Sara Grechko, Nikolay Bolsue, Pisita Giovanetti, Alessandro To, Christina Nahas, Myrna |
| author_facet | Flinn, Ian W. Jacobson, Caron Nastoupil, Loretta J. Morschhauser, Franck Davies, Andrew J. Buske, Christian Corradini, Paolo Lopez-Guillermo, Armando Reshef, Ran Parameswaran, Vinod Sehgal, Alison Tees, Michael Lui, Christine Xue, Wei Beygi, Sara Grechko, Nikolay Bolsue, Pisita Giovanetti, Alessandro To, Christina Nahas, Myrna |
| author_sort | Flinn, Ian W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431141 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311412023-08-17 P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA Flinn, Ian W. Jacobson, Caron Nastoupil, Loretta J. Morschhauser, Franck Davies, Andrew J. Buske, Christian Corradini, Paolo Lopez-Guillermo, Armando Reshef, Ran Parameswaran, Vinod Sehgal, Alison Tees, Michael Lui, Christine Xue, Wei Beygi, Sara Grechko, Nikolay Bolsue, Pisita Giovanetti, Alessandro To, Christina Nahas, Myrna Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431141/ http://dx.doi.org/10.1097/01.HS9.0000971324.63506.62 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Flinn, Ian W. Jacobson, Caron Nastoupil, Loretta J. Morschhauser, Franck Davies, Andrew J. Buske, Christian Corradini, Paolo Lopez-Guillermo, Armando Reshef, Ran Parameswaran, Vinod Sehgal, Alison Tees, Michael Lui, Christine Xue, Wei Beygi, Sara Grechko, Nikolay Bolsue, Pisita Giovanetti, Alessandro To, Christina Nahas, Myrna P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA |
| title | P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA |
| title_full | P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA |
| title_fullStr | P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA |
| title_full_unstemmed | P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA |
| title_short | P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA |
| title_sort | p1107: zuma-22: a phase 3, randomized controlled study of axicabtagene ciloleucel versus standard-of-care therapy in patients with relapsed or refractory follicular lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431141/ http://dx.doi.org/10.1097/01.HS9.0000971324.63506.62 |
| work_keys_str_mv | AT flinnianw p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT jacobsoncaron p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT nastoupillorettaj p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT morschhauserfranck p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT daviesandrewj p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT buskechristian p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT corradinipaolo p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT lopezguillermoarmando p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT reshefran p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT parameswaranvinod p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT sehgalalison p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT teesmichael p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT luichristine p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT xuewei p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT beygisara p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT grechkonikolay p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT bolsuepisita p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT giovanettialessandro p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT tochristina p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma AT nahasmyrna p1107zuma22aphase3randomizedcontrolledstudyofaxicabtageneciloleucelversusstandardofcaretherapyinpatientswithrelapsedorrefractoryfollicularlymphoma |